News

For Immediate Release: November 28, 2016

Contact
Mary Kuramoto
513-579-9911 x2523
m.kuramoto@medpace.com

Medpace is Proud to Present Four Scientific Posters at AAPS This Year

CINCINNATI, OH — (November 28, 2016) – The 2016 Annual Meeting and Exposition for the American Association of Pharmaceutical Scientists (AAPS) is a gathering place for the brightest minds in pharmaceutical research. Founded in 1986, AAPS is an individual membership society of approximately 10,000 pharmaceutical scientists who have joined together to serve the public and their own common professional interests. To learn more about AAPS, visit www.aaps.org. This year, Medpace sent four professionals to present their scientific posters at the meeting in November.

About the Posters

Dr. Yong-xi Li, Executive Director of Medpace Bioanalytical Laboratories, Dr. Guangchun Zhou, Director of Medpace Bioanalytical Laboratories, Dr. Tian-Sheng Lu, Director of Medpace Bioanalytical Laboratories, and Dr. Aiping Zhu, Medpace analytical chemistry scientist, attended AAPS and presented four posters:

  • Quantification of Nicotine and its Metabolite Cotinine in Rat Tooth, Rat Alveolar Bone and Brain Using Triple Quad 5500 System
  • Simultaneous Quantification of Lathosterol, Lanosterol and Desmosterol in Human Plasma Using UPLC-Tandem Mass Spectrometry
  • Simultaneous Measurement of Dehydroepiandrosterone (DHEA) and 17 Hydroxyprogesterone(17-OHP) as Biomarkers in Human Plasma using UPLC-MS/MS
  • Simultaneous Measurement of Four Oxysterols in Human Serum by UPLC-APCI-MS/MS

To see the posters that were presented, please visit www.medpace.com

 

ABOUT MEDPACE

Medpace is a scientifically-driven, global full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services for drug, biologic, and device programs. Medpace’s physician-led, high-science, and disciplined operating approach leverages regulatory and therapeutic expertise to accelerate the global development of safe and effective medical therapeutics across all major areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, and neuroscience. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people worldwide with operations in 35 countries.

For more information, please visit www.medpace.com